The problem
A neurological diagnosis — Alzheimer’s disease, a stroke, POTS, PTSD — is usually met with medication and rehabilitation. Both matter: they ease symptoms and build function, and they remain part of good care.
What they do not reach is the damaged tissue itself, and neural damage left unaddressed tends to progress — with real daily costs in memory, mobility, and independence.
Regenerative protocols are designed to work at the level of the tissue itself.
The approach
Every Neorgana protocol is customized and multifactorial — built around the patient’s unique case by a multidisciplinary team, with expert guidance at every step.
It begins with thorough assessment and functional review. Supportive therapies prepare the body and create the right environment; regenerative therapies are administered when the patient is ready; and integration care continues afterward — because regeneration is more than any single administration.
For neurological and autonomic conditions, a plan may draw on cellular and signaling therapies from the Dezawa platform alongside autonomic protocols — combined according to the case, never as a single fixed treatment.
Where the autonomic nervous system is involved, Neorgana Stellate Ganglion + vagus nerve block therapy is designed to retrain and restore the nervous system — activating the body’s innate ability to reestablish balance, resilience, and neurological harmony.
Addressed within a customized protocol built around the individual case.
02Repair-focused cellular protocols for the recovering brain.
03Autonomic retraining through the Stellate Ganglion + vagus protocol, alongside cellular therapy.
04Nervous-system reset protocols designed to reestablish balance and resilience.
The science
Dezawa MuseCells® were discovered and developed by Dr. Mari Dezawa — Professor and Director of the Department of Stem Cell Biology and Histology at Tohoku University School of Medicine, and one of the most respected scientists in regenerative medicine. They reach Neorgana exclusively through MuseCell Innovations®, the global IP owner.
Browse the publicationsWe respect your privacy. Opening the language menu loads Google Translate, which sets its own cookies.
